• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Etopophos (etoposide phosphate) powder for injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2011

 

Summary View

 

WARNINGS

  • Injection site reactions may occur during the administration of Etopophos. Closely monitor the infusion site for possible infiltration during drug administration. No specific treatment for extravasation reactions is known.

ADVERSE REACTIONS

  • Local soft tissue toxicity has been reported following extravasation of Etopophos.